Unknown and unspecified causes of morbidity

R18_UNKNO_UNSPE_CAUSES_MORBIDI

disease: A disease is a disposition to undergo pathological processes that exists in an organism because of one or more disorders in that organism.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R69 Cause of death: ICD-10 — R69 2 out of 7 registries used, show all original rules.	3308
4. Check minimum number of events None	3308
5. Include endpoints None	3308
6. Filter based on genotype QC (FinnGen only)	3308

Control definitions (FinnGen only)

Control exclude: R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R[5-6]
Name in latin: Causae morborum ignotae sive non specificatae

NAME	R18_UNKNO_UNSPE_CAUSES_MORBIDI
CONTROL_EXCLUDE	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R69
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R69
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Unknown and unspecified causes of morbidity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3308	1829	1479
Unadjusted period prevalence (%)	0.64	0.62	0.65
Median age at first event (years)	50.74	46.25	56.29

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3016: Matched controls
30159

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

4503599627370496.0

323.0

3015

R51.80

ICD-10 Finland

Headache

8.8

206.6

476

632

R50.9

ICD-10 Finland

Fever, unspecified

9.3

192.2

425

523

R55

ICD-10 Finland

Syncope and collapse

19.9

189.7

293

162

R56.8

ICD-10 Finland

Other and unspecified convulsions

301.7

141.7

143

SPAT1249

SPAT

Treatment-related counselling outside office

2.6

123.7

1398

7605

SPAT1301

SPAT

No procedures

2.7

120.1

1138

5572

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

113.9

1167

5930

UJD02

NOMESCO Finland

Gastroscopy

6.6

113.1

311

518

R53

ICD-10 Finland

Malaise and fatigue

3.7

112.8

573

1819

SPAT1229

SPAT

Assessment of need for aid

5.2

109.7

369

787

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.0

104.9

730

2904

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

3.4

102.7

566

1903

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

4.6

102.2

390

949

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.6

96.6

361

857

XG460

NOMESCO Finland

Short time oxymetry

12.8

95.3

174

143

N05AH04

ATC

quetiapine; oral

3.2

94.9

589

2151

SPAT1240

SPAT

Therapeutic discussion

3.7

94.5

462

1404

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.4

94.2

1075

5645

N03AX16

ATC

pregabalin; oral

2.8

93.8

745

3196

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.1

93.3

599

2236

A60

ICPC

General and Unspecified, Result test/procedure

6.0

91.6

270

489

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

4.8

89.8

325

744

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

12.4

83.8

155

131

ZX100

NOMESCO Finland

Oral

14.2

82.8

144

106

ZYC01

NOMESCO Finland

Remote contact by phone

5.8

81.5

246

457

SPAT1235

SPAT

Mental health, emotional support

22.3

80.2

118

A02BC02

ATC

pantoprazole; systemic

2.1

79.8

1860

13137

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

8.8

79.4

177

213

ZX140

NOMESCO Finland

Intra articular

22.9

78.9

115

Z25.1

ICD-10 Finland

Need for immunization against influenza

4.5

77.3

295

710

R06.0

ICD-10 Finland

Dyspnoea

2.4

75.9

762

3668

N05BA04

ATC

oxazepam; oral

2.4

75.5

795

3917

XF600

NOMESCO Finland

Bloodpressure measurement

4.6

75.3

278

646

N06AX16

ATC

venlafaxine; oral

3.1

74.9

469

1699

N02AX02

ATC

tramadol; systemic, rectal

2.1

74.0

1227

7441

N05AH03

ATC

olanzapine; systemic

4.7

73.4

266

606

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

72.7

430

1494

H02AB06

ATC

prednisolone; systemic

2.0

69.4

1359

8746

M54.5

ICD-10 Finland

Low back pain

2.1

67.8

962

5407

IHZ04

SPAT

32.7

67.4

N06AX11

ATC

mirtazapine; oral

2.1

66.9

936

5219

IGY02

SPAT

21.3

66.5

M79.6

ICD-10 Finland

Pain in limb

2.1

66.3

1012

5857

N03AX12

ATC

gabapentin; oral

2.9

66.0

466

1815

ZYC01

SPAT

4.0

63.9

275

737

R52.9

ICD-10 Finland

Pain, unspecified

4.1

63.5

266

696

ZX120

NOMESCO Finland

Intravenous

3.3

63.2

358

1197

UJF32

NOMESCO Finland

Coloscopy

2.2

63.1

755

3905

WZC30

NOMESCO Finland

Teaching

2.8

61.3

453

1808

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.6

60.9

187

353

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

60.3

371

1315

A29

ICPC

General symptom/complaint other

3.0

60.0

385

1405

R52.2

ICD-10 Finland

Other chronic pain

9.4

59.9

127

140

N03AE01

ATC

clonazepam; systemic

4.3

59.0

231

566

A62

ICPC

General and Unspecified, Administrative procedure

6.6

59.0

157

247

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.6

58.4

466

1945

N05AX12

ATC

aripiprazole; systemic

5.5

58.1

181

348

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

57.6

550

2531

SPAT1310

SPAT

Counselling related to known health issue

2.0

57.5

974

5805

R39.1

ICD-10 Finland

Other difficulties with micturition

6.0

56.8

164

287

ICB03

SPAT

52.6

56.1

SPAT1234

SPAT

Support of social functional capacity

4.6

56.0

203

461

C07AB07

ATC

bisoprolol; oral

1.9

55.5

1254

8284

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

55.5

729

3899

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.4

55.5

175

341

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.9

55.4

367

1363

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

5.3

55.4

176

346

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.5

54.7

510

2311

N06AX21

ATC

duloxetine; oral

3.1

54.6

331

1159

N03AG01

ATC

valproic acid; systemic, rectal

4.2

54.2

218

548

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.2

53.8

307

1028

N03AX09

ATC

lamotrigine; oral

5.1

52.9

175

360

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

52.1

843

4891

IHZ05

SPAT

6.9

52.1

134

201

R60.0

ICD-10 Finland

Localized oedema

3.5

51.8

258

779

Z71.8

ICD-10 Finland

Other specified counselling

2.1

51.7

721

3938

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

51.7

686

3668

L28

ICPC

Limited function/disability (L)

2.5

51.1

444

1931

R42

ICD-10 Finland

Dizziness and giddiness

2.2

51.0

588

2952

CK2S4

SPAT

18.4

50.7

L17

ICPC

Foot/toe symptom/complaint

2.1

50.7

712

3894

N02AA05

ATC

oxycodone; systemic

2.6

50.6

404

1675

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

5.4

50.3

158

306

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

9.0

50.3

109

125

SPAT1263

SPAT

Sampling

1.8

49.8

1209

8093

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

49.0

623

3260

Z00.8

ICD-10 Finland

Other general examinations

3.3

48.8

270

883

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.2

48.6

274

908

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

48.5

795

4614

Z01.2

ICD-10 Finland

Dental examination

1.8

48.3

1178

7876

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.4

48.1

253

797

SPAT1312

SPAT

General health counselling

1.9

47.8

952

5935

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

47.6

756

4332

A02BC05

ATC

esomeprazole; systemic

1.8

47.4

1113

7335

IGY99

SPAT

12.2

47.3

J01DB01

ATC

cefalexin; oral

1.9

47.3

2310

19204

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.7

47.3

357

1432

ZXH09

SPAT

6.3

47.2

130

214

R06.5

ICD-10 Finland

Mouth breathing

3.0

46.4

289

1023

SPAT1254

SPAT

Administration of medicine

2.4

45.8

430

1942

SPAT1360

SPAT

Extensive global examination

3.0

45.7

280

981

N02BE01

ATC

paracetamol; systemic, rectal

1.9

45.6

2402

20323

ZXH06

SPAT

6.2

45.5

127

213

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

45.5

604

3209

Z2221

NOMESCO Finland

Medical doctor

0.4

45.3

222

4963

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.6

45.2

215

625

C03CA01

ATC

furosemide; systemic

2.0

45.0

748

4346

N05AX08

ATC

risperidone; systemic

3.1

45.0

267

917

B04

ICPC

Blood symptom/complaint

30.6

45.0

S18

ICPC

Laceration/cut

1.8

44.4

1117

7483

WW200

SPAT

2.5

43.8

370

1578

N06AB04

ATC

citalopram; systemic

2.1

43.0

605

3286

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.2

42.9

138

275

N05CF01

ATC

zopiclone; oral

1.9

42.9

872

5431

IEV99

SPAT

95.5

42.9

J01DA01

ATC

[U] cefalexin; systemic

1.7

42.8

1795

13969

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

42.3

1056

7028

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

42.3

1230

8584

N06AB10

ATC

escitalopram; oral

2.1

42.2

573

3062

M01AE02

ATC

naproxen; oral, rectal

1.7

41.8

1582

11911

N05BA01

ATC

diazepam; systemic, rectal

2.4

41.8

392

1766

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.2

41.7

238

794

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

4.2

41.7

168

422

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.5

41.7

156

365

A28

ICPC

Limited function/disability NOS

2.4

41.5

386

1731

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

41.5

468

2305

R4110

SPAT

5.5

41.5

127

239

R11

ICD-10 Finland

Nausea and vomiting

3.1

41.5

243

826

SPAT1262

SPAT

Handing over of treatment supplies

2.1

41.5

525

2720

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

41.1

494

2501

A69

ICPC

General and Unspecified, Other reason for encounter NEC

5.2

41.1

132

263

J01MA02

ATC

ciprofloxacin; systemic

1.8

40.9

1030

6854

N05AA02

ATC

levomepromazine; systemic

4.3

40.8

160

392

WX199

NOMESCO Finland

Other local analgesia

5.4

40.8

126

240

Z3231

NOMESCO Finland

Registered nurse

0.4

40.4

211

4623

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

13.7

40.3

C07AA05

ATC

propranolol; systemic

2.1

39.6

545

2920

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.8

39.3

271

1023

J01MA12

ATC

levofloxacin; systemic

2.1

38.9

499

2594

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

11.5

38.7

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

38.4

447

2227

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

38.4

805

5031

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.2

37.6

206

667

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

37.5

369

1696

N06AX12

ATC

bupropion; oral

3.3

37.4

201

642

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.0

37.4

229

801

S02.59

ICD-10 Finland

Tooth fracture UNS

5.1

37.3

121

244

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.5

37.1

113

212

SPAT1255

SPAT

Intravenous administration of medicine

3.1

37.0

216

731

N06AA09

ATC

amitriptyline; systemic

2.6

36.9

285

1151

SPAT1153

SPAT

Removal of sutures

1.8

36.7

865

5595

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

15.2

36.6

XG466

NOMESCO Finland

Sleep oxymetry

4.5

36.3

133

305

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

36.1

252

956

L03

ICPC

Low back symptom/complaint

1.9

35.5

643

3805

OAB40

SPAT

26.2

35.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

35.1

1074

7488

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.5

35.1

307

1327

N06AB03

ATC

fluoxetine; oral

2.3

35.1

363

1707

R52.1

ICD-10 Finland

Chronic intractable pain

67.4

35.0

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

8.6

34.9

H02BX01

ATC

methylprednisolone, combinations; systemic

3.2

34.6

195

642

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.2

34.1

402

2006

K59.09

ICD-10 Finland

Constipation, unspecified

3.4

34.0

176

546

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

33.7

236

900

A06AD11

ATC

lactulose; oral

2.2

33.6

377

1840

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

33.6

454

2401

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.8

33.6

149

408

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

18.2

33.6

S06.0

ICD-10 Finland

Concussion

2.5

33.5

281

1187

M25.5

ICD-10 Finland

Pain in joint

1.8

33.5

740

4667

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

33.2

380

1869

L12

ICPC

Hand/finger symptom/complaint

2.1

33.0

392

1963

A04

ICPC

Weakness/tiredness general

2.3

32.9

340

1597

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

32.8

355

1702

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

14.7

32.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

32.5

566

3291

SPAT1285

SPAT

Provision of consultation response

3.1

32.3

183

606

R07.3

ICD-10 Finland

Other chest pain

2.5

32.3

263

1092

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

32.2

178

580

N06AB06

ATC

sertraline; oral

2.3

31.9

311

1418

SPAT1216

SPAT

Assessment of functional ability

2.1

31.7

395

2014

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

31.6

259

1077

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.9

31.6

136

363

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

31.4

621

3767

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

31.4

361

1776

J01AA02

ATC

doxycycline; systemic

1.6

31.4

2133

18058

R03AC02

ATC

salbutamol; inhalant

1.6

31.4

1389

10578

M79.1

ICD-10 Finland

Myalgia

2.2

31.2

349

1698

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.1

31.0

111

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

31.0

615

3733

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

30.9

1021

7203

Z97.4

ICD-10 Finland

Presence of external hearing-aid

3.2

30.7

166

532

ZY010

SPAT

9.3

30.6

K02.1

ICD-10 Finland

Caries of dentine

1.6

30.6

1519

11863

R5140

SPAT

19.4

30.4

G44.2

ICD-10 Finland

Tension-type headache

2.2

30.3

327

1563

A99

ICPC

Disease/condition unspecnature/site

2.6

30.2

235

950

R5110

SPAT

4.9

30.1

102

216

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.3

30.1

134

XCH00

NOMESCO Finland

Eye pressure measurement

3.5

30.1

146

431

HMAK

NOMESCO Finland

2.1

30.0

375

1914

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.2

30.0

135

N03AF02

ATC

oxcarbazepine; oral

5.1

29.9

192

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.7

29.7

209

799

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.3

29.4

111

263

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

29.3

1255

9425

H02AB04

ATC

methylprednisolone; systemic

2.0

29.2

400

2119

IHZ07

SPAT

14.6

29.2

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

29.2

938

6545

T99

ICPC

Endocr/metab/nutrit disease other

6.4

29.0

122

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

28.9

670

4260

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.8

28.9

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.3

28.7

171

N07BB01

ATC

disulfiram; oral

3.6

28.7

136

394

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.2

28.7

112

274

OAB42

SPAT

2.9

28.6

179

634

WZC00

SPAT

3.1

28.4

162

540

ZXE00

NOMESCO Finland

One hour or less

1.6

28.3

1049

7577

B01AA03

ATC

warfarin; systemic

1.8

28.2

520

3068

F61.0

ICD-10 Finland

Mixed personality disorders

6.5

28.1

116

R74

ICPC

Upper respiratory infection acute

1.7

28.0

749

4960

XF404

NOMESCO Finland

Ambulatory ECG

2.4

27.9

242

1039

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

27.8

247

1071

K30

ICD-10 Finland

Functional dyspepsia

2.3

27.8

281

1301

K08.80

ICD-10 Finland

Toothache NOS

2.5

27.8

233

982

G47.3

ICD-10 Finland

Sleep apnoea

1.8

27.8

530

3162

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.7

27.8

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

27.7

520

3085

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.3

27.7

105

250

SPAT1241

SPAT

Extensive assessment of psychosocial situation

7.1

27.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

27.3

1114

8222

R02

ICPC

Shortness of breath/dyspnoea

2.2

27.3

306

1487

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

27.2

555

3383

A31

ICPC

General and Unspecified, Medical examin/health eval partial

3.9

27.0

113

295

SPAT1325

SPAT

Vaccination

1.6

26.9

909

6396

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.2

26.7

279

1313

R60.9

ICD-10 Finland

Oedema, unspecified

3.9

26.6

111

289

N30.0

ICD-10 Finland

Acute cystitis

2.1

26.6

346

1791

Z3226

NOMESCO Finland

Physiotherapist

0.4

26.5

119

2795

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.3

26.5

R05

ICD-10 Finland

Cough

1.8

26.4

486

2861

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

26.4

249

1115

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

26.4

162

567

SPAT1260

SPAT

Consultation of another employee

1.9

26.4

463

2682

ZYC02

SPAT

4.7

26.2

199

M54.2

ICD-10 Finland

Cervicalgia

2.6

26.1

195

771

M02AA10

ATC

ketoprofen; topical

1.9

26.0

425

2397

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.1

26.0

103

256

Z00.0

ICD-10 Finland

General medical examination

1.8

25.7

498

2978

P01

ICPC

Feeling anxious/nervous/tense

2.2

25.4

284

1379

A02BC03

ATC

lansoprazole; oral

1.6

25.3

732

4931

J01MA14

ATC

moxifloxacin; systemic

2.3

25.2

241

1085

IFA99

SPAT

35.9

25.2

M35.7

ICD-10 Finland

Hypermobility syndrome

6.4

25.2

107

R00.2

ICD-10 Finland

Palpitations

2.5

25.0

198

809

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.2

25.0

283

1380

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

24.9

395

2203

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

24.9

711

4770

SPAT1276

SPAT

Outlining of treatment with patient or their family members

4.4

24.8

210

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

24.8

282

1376

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.7

24.7

129

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

5.1

24.7

158

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.3

24.6

127

394

M54.6

ICD-10 Finland

Pain in thoracic spine

2.7

24.5

178

693

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.6

24.5

190

766

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.5

24.5

201

839

SPAT1324

SPAT

Screening procedure

1.8

24.4

467

2777

P01AB01

ATC

metronidazole; oral, rectal

1.5

24.4

992

7265

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

24.3

441

2576

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

48.7

24.3

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

24.2

501

3056

P99

ICPC

Psychological disorders other

4.0

24.2

249

A03

ICPC

Fever

1.9

24.2

407

2320

QDH05

NOMESCO Finland

Correction of deformity of toe nail

25.6

23.9

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.4

23.8

135

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.7

23.7

168

642

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

9.7

23.7

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.3

23.7

221

985

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.7

23.5

514

3187

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

23.5

729

4987

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

23.5

277

1373

L16

ICPC

Ankle symptom/complaint

2.2

23.5

264

1284

M48.0

ICD-10 Finland

Spinal stenosis

2.1

23.4

288

1454

M01AH02

ATC

rofecoxib; oral

2.0

23.3

339

1832

S97

ICPC

Chronic ulcer skin

3.0

23.2

135

457

L15

ICPC

Knee symptom/complaint

1.7

23.2

514

3200

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

7.1

23.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

4.0

23.0

236

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

23.0

276

1378

N05CD07

ATC

temazepam; oral

2.0

23.0

321

1704

79199

ICD-8 Finland

Headache

+∞

22.9

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

22.9

203

881

S02.51

ICD-10 Finland

Fracture of tooth, open

2.1

22.9

275

1373

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

22.9

248

1184

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.5

22.9

M01AX17

ATC

nimesulide; oral

1.7

22.9

600

3922

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

22.8

302

1570

N30.9

ICD-10 Finland

Cystitis, unspecified

2.8

22.8

149

544

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

22.8

292

1500

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

22.8

195

830

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

22.6

1056

7949

H02AB07

ATC

prednisone; oral

1.9

22.6

372

2100

P29

ICPC

Psychological sympt/compl other

2.7

22.5

162

628

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

22.5

299

1558

R29

ICPC

Respiratory symptom/complaint other

2.6

22.4

175

710

N05AN01

ATC

lithium; oral

4.3

22.3

200

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.9

22.1

152

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.2

22.1

ZX114

NOMESCO Finland

Intramuscular

6.0

22.1

103

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

22.1

567

3679

UJG02

NOMESCO Finland

Proctoscopy

4.2

22.0

207

A63

ICPC

General and Unspecified, Follow-up encounter unspecified

11.9

22.0

N01

ICPC

Headache

2.1

22.0

249

1215

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

21.9

297

1560

A34

ICPC

General and Unspecified, Blood test

5.7

21.9

112

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

21.7

869

6301

R12

ICD-10 Finland

Heartburn

2.4

21.7

187

800

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.2

21.7

119

387

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

21.6

207

931

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

21.6

1831

15519

Z29

ICPC

Social problem NOS

4.7

21.5

161

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

21.4

168

682

TAB20

NOMESCO Finland

Epidural puncture

8.4

21.4

UDC00

NOMESCO Finland

Ear microscopy

2.3

21.3

205

924

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

3.5

21.3

100

289

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

21.3

312

1686

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

21.3

288

1508

OAB47

SPAT

4.1

21.3

214

N05BE01

ATC

buspirone; oral

3.8

21.2

239

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

21.2

1357

10859

K04.1

ICD-10 Finland

Necrosis of pulp

2.0

21.1

277

1435

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

21.1

141

522

N17

ICPC

Vertigo/dizziness

2.1

21.0

257

1293

N06AB05

ATC

paroxetine; oral

2.5

21.0

175

734

M79.7

ICD-10 Finland

Fibromyalgia

3.8

20.9

247

L14

ICPC

Leg/thigh symptom/complaint

2.4

20.9

181

776

Z29.8

ICD-10 Finland

Other specified prophylactic measures

3.8

20.8

248

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

20.8

279

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

3.1

20.8

120

404

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.5

20.8

285

OAB44

SPAT

2.9

20.7

131

470

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

20.6

599

4007

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.1

20.6

A30

ICPC

General and Unspecified, Medical examin/health eval complete

4.2

20.5

193

KMAK

NOMESCO Finland

1.4

20.4

1344

10786

IHA10

SPAT

10.7

20.4

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

20.3

472

2968

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

20.3

241

1196

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

14.3

20.3

WZA10

NOMESCO Finland

Long statement of health and health related matters

5.2

20.3

123

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.8

20.3

239

N06AX03

ATC

mianserin; oral

2.9

20.2

129

465

N03AF01

ATC

carbamazepine; oral, rectal

2.8

20.2

131

476

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

20.1

1386

11211

ZXD05

NOMESCO Finland

Urgent procedure

1.5

20.0

773

5540

R03DC03

ATC

montelukast; oral

1.8

20.0

397

2381

K78

ICPC

Atrial fibrillation/flutter

2.3

20.0

191

860

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

20.0

135

504

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.8

19.8

131

483

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.2

19.8

180

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.2

19.8

185

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

19.7

367

2154

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

19.6

298

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

19.6

147

581

ZYY01

SPAT

24.7

19.5

C01DA14

ATC

isosorbide mononitrate; oral

1.8

19.5

379

2254

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

19.5

681

4762

P01BA02

ATC

hydroxychloroquine; oral

2.2

19.5

210

1000

D01

ICPC

Abdominal pain/cramps general

2.0

19.5

272

1441

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

19.4

515

3359

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

19.4

228

1126

A02BA02

ATC

ranitidine; systemic

1.7

19.4

477

3048

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

19.4

1348

10896

F10.24

ICD-10 Finland

Alcohol depence active use

6.7

19.3

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.2

19.2

196

910

WX110

NOMESCO Finland

Local anesthesy

1.4

19.2

1779

15162

N05CF02

ATC

zolpidem; oral

1.7

19.1

417

2572

L01

ICPC

Neck symptom/complaint

1.9

19.1

322

1826

SPAT1353

SPAT

Intensive monitoring

9.0

19.1

A01

ICPC

Pain general/multiple sites

2.3

19.0

182

820

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

19.0

312

1756

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.7

18.9

142

L11

ICPC

Wrist symptom/complaint

2.2

18.9

209

1008

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.1

18.9

216

1057

J01FA10

ATC

azithromycin; systemic

1.4

18.8

1487

12277

EBA00

NOMESCO Finland

Extraction of tooth

1.5

18.7

804

5883

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.3

18.7

172

761

Z29.0

ICD-10 Finland

Isolation

17.2

18.7

R52.0

ICD-10 Finland

Acute pain

4.8

18.6

131

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

18.6

134

519

P15

ICPC

Chronic alcohol abuse

3.9

18.6

206

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.6

18.6

140

IAB01

SPAT

20.9

18.6

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.0

18.6

QDH

NOMESCO Finland

Operations on toe nails

100.6

18.6

K29

ICPC

Cardiovascular sympt/complt other

3.0

18.6

109

373

XG405

NOMESCO Finland

Education on PEF monitoring

5.6

18.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

18.5

536

3572

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

18.4

129

491

R05FB02

ATC

cough suppressants and expectorants

1.5

18.4

953

7250

R51

ICD-10 Finland

Headache

3.2

18.4

319

R13

ICD-10 Finland

Dysphagia

2.4

18.4

159

682

M03BX02

ATC

tizanidine; oral

1.4

18.4

1529

12726

N06AX26

ATC

vortioxetine; oral

2.5

18.4

146

598

R06.2

ICD-10 Finland

Wheezing

2.8

18.2

121

449

P03

ICPC

Feeling depressed

2.1

18.1

225

1139

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.3

18.1

A02BC01

ATC

omeprazole; systemic

1.5

18.1

653

4593

J01FF01

ATC

clindamycin; systemic

1.5

18.0

649

4561

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

5.1

18.0

114

C07AB02

ATC

metoprolol; systemic

1.6

17.9

507

3359

K04.0

ICD-10 Finland

Pulpitis

2.0

17.9

254

1354

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.5

17.9

140

569

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

7.7

17.8

AA1AD

NOMESCO Finland

CT of head and brain

1.7

17.7

447

2869

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.5

17.7

246

IAA02

SPAT

67.0

17.7

UKC02

NOMESCO Finland

Cystoscopy

1.7

17.7

381

2336

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.1

17.7

323

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.5

17.6

N05BA12

ATC

alprazolam; oral

2.0

17.6

248

1316

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.2

17.6

301

WX290

NOMESCO Finland

Other blockade of nerve

1.4

17.6

1106

8715

AA400

NOMESCO Finland

Electroconvulsive therapy

7.0

17.6

J01FA06

ATC

roxithromycin; oral

1.4

17.6

1007

7797

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

17.6

638

4487

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.0

17.5

J01EA01

ATC

trimethoprim; systemic

1.5

17.5

606

4218

-1

NOMESCO Finland

1.5

17.4

839

6275

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

17.4

143

597

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.9

17.3

110

395

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

17.2

199

978

L08

ICPC

Shoulder symptom/complaint

1.6

17.1

436

2805

N03AX11

ATC

topiramate; oral

3.9

17.1

187

N05AE04

ATC

ziprasidone; systemic

10.8

16.9

N05AH02

ATC

clozapine; systemic

4.1

16.9

164

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.3

16.9

150

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

16.9

141

595

M01AH05

ATC

etoricoxib; oral

1.4

16.9

1456

12119

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

16.9

189

915

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

16.8

151

658

N04BC05

ATC

pramipexole; oral

2.2

16.8

172

800

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

16.8

318

1876

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.0

16.8

335

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.8

1268

10309

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.4

16.7

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

16.7

279

1578

K10.3

ICD-10 Finland

Alveolitis of jaws

2.6

16.7

124

491

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

16.7

225

1177

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

16.7

174

817

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.0

16.7

233

1236

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

16.7

161

729

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

15.1

16.6

N05AF03

ATC

chlorprothixene; systemic

3.4

16.5

244

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

16.4

16.5

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.4

16.5

144

621

A46

ICD-10 Finland

Erysipelas

1.8

16.5

305

1781

N05AB03

ATC

perphenazine; systemic, rectal

3.0

16.5

339

N06AX05

ATC

trazodone; oral

3.6

16.5

208

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

18.0

16.4

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

16.4

137

576

M03BX01

ATC

baclofen; systemic

4.9

16.4

109

R63.4

ICD-10 Finland

Abnormal weight loss

3.9

16.4

179

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.4

16.3

146

638

B01AB05

ATC

enoxaparin; parenteral

1.5

16.3

697

5071

H02AB09

ATC

hydrocortisone; systemic

4.0

16.3

165

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.6

16.3

123

490

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

16.2

687

4987

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.8

16.2

108

400

R07.0

ICD-10 Finland

Pain in throat

2.3

16.2

155

697

C05AA08

ATC

fluocortolone; rectal, topical

1.7

16.2

346

2119

D73

ICPC

Gastroenteritis presumed infection

3.2

16.1

265

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

3.4

16.1

238

P76

ICPC

Depressive disorder

2.3

16.1

150

668

M02AA07

ATC

piroxicam; topical

1.4

16.1

873

6661

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

16.1

210

1086

B02.9

ICD-10 Finland

Zoster without complication

2.4

16.1

135

571

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

16.0

1423

11859

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

16.0

409

2631

M01AC06

ATC

meloxicam; systemic, rectal

1.4

16.0

862

6570

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

16.0

100

358

K08.3

ICD-10 Finland

Retained dental root

2.2

15.9

166

779

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.5

15.9

129

537

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.7

15.9

318

1906

R01AD11

ATC

triamcinolone; nasal

1.9

15.8

232

1253

Z3232

NOMESCO Finland

Midwife

0.3

15.8

1032

U07

ICPC

Urine symptom/complaint other

2.3

15.8

144

634

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

15.7

1633

13954

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

15.6

OAB40

NOMESCO Finland

Guidance related to intoxicants/hazardous behaviour

+∞

15.6

B60

ICPC

Blood and Immunity, Result test/procedure

4.5

15.5

125

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

15.5

463

3099

IAA01

SPAT

11.8

15.5

NBG10

NOMESCO Finland

Acromioplastia

3.1

15.5

279

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

160.7

15.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

15.4

148

670

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

15.4

309

1853

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

15.3

171

827

H25.0

ICD-10 Finland

Senile incipient cataract

2.2

15.3

159

744

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

15.3

254

1433

T74.1

ICD-10 Finland

Physical abuse

4.1

15.3

146

A59

ICPC

General and Unspecified, Other therap proced/minor surg NEC

5.3

15.3

J01CA04

ATC

amoxicillin; systemic

1.4

15.2

2176

19566

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.8

15.2

171

ZXA00

NOMESCO Finland

Right side

1.5

15.2

625

4500

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.9

15.1

162

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

15.1

298

1777

J45.8

ICD-10 Finland

Mixed asthma

3.1

15.1

273

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.6

15.1

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

15.0

231

1267

H03AA01

ATC

levothyroxine sodium; systemic

1.5

15.0

552

3881

OAB38

SPAT

4.5

15.0

116

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.8

15.0

257

1467

SPAT1097

SPAT

Recording of ECG

1.7

15.0

325

1996

T29

ICPC

Endocr/metab/nutr sympt/compl other

3.9

14.9

159

H92.0

ICD-10 Finland

Otalgia

2.4

14.9

124

521

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.0

14.8

D07AC13

ATC

mometasone; topical

1.5

14.8

713

5301

SPAT1251

SPAT

Organisation of medication

2.7

14.8

100

375

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

14.8

370

2363

SPAT1284

SPAT

Extensive health certificate

3.0

14.7

295

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.0

14.7

147

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

14.6

344

2159

U04

ICPC

Incontinence urine

2.6

14.6

110

439

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

14.6

409

2692

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

14.6

266

1549

SPAT1243

SPAT

Psychiatric/psychological examination

3.2

14.5

247

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

14.5

166

814

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.6

14.5

111

EBCD

NOMESCO Finland

150.7

14.5

SPAT1104

SPAT

Monitoring of emergency patient

2.1

14.5

158

757

AN1

Coronary angiography

1.8

14.5

247

1407

M54.3

ICD-10 Finland

Sciatica

2.3

14.5

136

610

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

14.4

460

3126

R06AE07

ATC

cetirizine; oral

1.4

14.4

1063

8536

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

14.4

475

3253

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

14.4

323

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022217) INR in Platelet poor plasma by Coagulation assay

1177

2552

6.61

307.65

12.9

24.9

inr

1.3

1.4

1.03

513

366

(3030981) Hyaline casts [#/volume] in Urine by Automated count

568

1096

6.05

288.32

4.0

2.4

e6/l

0.3

0.27

562

1058

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

483

845

6.52

270.40

2.2

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

418

766

6.10

221.84

2.1

1.6

—

(3013512) EKG study

1397

6482

3.00

198.53

4.3

3.5

—

(4034850)

363

772

5.16

162.22

9.4

7.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

260

417

6.68

156.49

4.1

2.9

mmol/l

24.1

24.8

1.66

194

362

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

549

1797

3.46

136.03

3.3

2.4

ml/min/173m2

72.8

68.8

1.83

357

690

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

109

17.86

133.85

2.5

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1277

6650

2.50

132.43

3.7

2.2

u/l

57.2

59.2

0.30

1238

6107

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

883

3895

2.73

128.61

4.4

3.2

ng/l

308.5

561.6

1.97

437

2962

(3028626) Oxygen [Partial pressure] in Capillary blood

223

377

6.27

127.08

3.7

2.7

kpa

8.2

0.25

182

343

(40760892) CBC W Ordered Manual Differential panel - Blood

1064

5191

2.55

125.70

5.9

3.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2017

13167

2.36

121.64

6.1

3.9

mmol/l

6.7

0.26

1933

12102

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

724

3027

2.78

115.72

2.1

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

154

193

8.32

115.16

3.3

3.2

mg/l

47.9

39.7

0.18

106

144

(3021901) Oxygen saturation in Capillary blood

187

297

6.61

113.18

3.3

2.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

965

4783

2.44

107.48

1.7

1.6

pmol/l

453.5

32350421.1

3.79

854

4000

(3044640) Blood type and Crossmatch panel - Blood

1302

7344

2.27

107.37

2.7

2.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1131

6041

2.33

105.91

3.0

1.9

u/l

172.7

237.2

1.10

1092

5619

(3027273) Bicarbonate [Moles/volume] in Venous blood

317

874

3.91

100.32

5.1

2.8

mmol/l

24.7

25.0

0.76

310

849

(3036481) Cortisol [Moles/volume] in Serum or Plasma

478

1721

3.08

99.42

2.5

2.0

nmol/l

340.6

380.9

5.01

453

1549

(3020891) Body temperature

283

729

4.15

98.34

6.5

4.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

459

1673

3.02

93.12

2.7

2.1

ug/l

4.2

7.9

8.95

437

1461

(3026008) Bacteria identified in Urine by Culture

1149

6454

2.20

92.78

3.9

2.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1723

11418

2.06

88.61

7.3

5.0

umol/l

10.6

11.5

1.78

1670

10780

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1020

5564

2.20

87.74

2.6

2.1

—

(3022689) Creatine [Moles/volume] in Urine

13.37

85.44

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

1847

23831

0.49

83.80

12.1

11.8

40.8

40.0

6.01

1207

17667

(3017181) Myelocytes/100 leukocytes in Blood

453

1770

2.81

80.32

5.9

3.7

1.0

0.8

0.45

157

410

(3019150) Specific gravity of Urine by Refractometry

928

5053

2.16

78.80

4.9

3.4

kg/l

1.0

0.81

765

(3019225) pH of Specimen

516

2175

2.63

78.73

4.2

3.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

435

1711

2.78

75.94

6.0

3.7

0.1

0.11

142

383

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

343

1190

3.10

75.20

4.2

3.2

kpa

5.1

5.2

1.04

296

1090

(3029937) Albumin [Presence] in Urine by Test strip

1057

6181

2.04

73.32

5.3

3.4

estimate

0.0

1.28

319

2035

(3024561) Albumin [Mass/volume] in Serum or Plasma

1428

9365

1.92

70.29

5.8

4.1

g/l

35.7

36.0

1.17

1363

8648

(3028707) Methadone [Presence] in Urine by Screen method

166

367

4.71

69.89

6.1

3.1

—

(3009343) pH of Capillary blood

328

1174

2.99

67.88

4.1

3.3

7.4

0.90

123

(3019309) Folate [Moles/volume] in Red Blood Cells

740

3918

2.14

65.95

1.9

1.7

nmol/l

1357.5

1149.5

7.69

641

2902

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

298

1040

3.05

64.38

2.0

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2324

18227

1.92

62.20

10.0

6.1

u/l

77.7

76.8

0.33

2280

17040

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

724

3890

2.10

61.61

2.7

2.8

mmol/l

2.4

2.81

691

3379

(3002032) Base excess in Venous blood by calculation

399

1667

2.58

61.17

5.4

3.1

mmol/l

1.7

1.8

0.05

318

1305

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

960

5742

1.95

60.26

3.1

2.7

ng/l

1593.6

1461.1

0.30

869

4838

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1409

9548

1.83

59.67

2.6

2.1

nmol/l

76.3

77.0

0.42

1357

8564

(3013650) Neutrophils [#/volume] in Blood by Automated count

1829

13408

1.81

59.62

12.3

7.5

e9/l

4.1

4.0

0.92

1760

11575

(3021447) Carbon dioxide [Partial pressure] in Venous blood

394

1667

2.55

58.73

5.5

3.1

kpa

6.0

5.8

3.02

378

1618

(3013707) Erythrocyte sedimentation rate by Westergren method

2268

17847

1.86

57.56

6.0

3.5

mm/h

11.7

11.2

0.97

2184

16426

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

303

1139

2.83

57.05

3.9

3.2

mmol/l

1.7

0.06

206

827

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1223

8031

1.83

56.64

4.5

2.9

ng/l

40.3

53.3

0.79

772

5099

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1522

10701

1.78

55.80

8.9

5.6

mmol/l

1.2

0.37

1359

8997

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

15.06

55.40

3.2

2.0

—

(3023368) Bacteria identified in Blood by Culture

878

5227

1.93

55.08

4.9

3.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

566

2877

2.17

55.04

2.9

1.7

1.5

1.4

4.90

535

2578

(3005719) IgG [Mass/volume] in Serum or Plasma

344

1406

2.61

54.93

4.1

2.5

g/l

10.3

10.6

0.53

325

1259

(3004809) Band form neutrophils/100 leukocytes in Blood

131

291

4.65

54.77

4.2

3.1

1.7

1.3

0.41

213

(3002179) Metamyelocytes/100 leukocytes in Blood

378

1624

2.50

54.38

4.7

3.5

0.8

0.5

1.00

290

(3015377) Calcium [Moles/volume] in Serum or Plasma

1145

7445

1.82

54.23

3.3

2.9

mmol/l

2.3

2.4

3.72

1087

6464

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

209

654

3.34

54.03

2.1

1.8

ug/l

2.8

2.6

0.06

195

568

(3002582) Erythrocytes [#/volume] in Urine

1028

6484

1.85

53.63

4.3

2.8

e6/l

50.3

94.7

1.53

930

4842

(3025159) Blasts/100 leukocytes in Blood

372

1620

2.46

51.87

6.2

3.7

0.6

0.4

0.16

323

(3031040) Bacteria [#/volume] in Urine by Automated count

2021

15640

1.75

51.06

5.7

3.7

e6/l

499.9

2170.3

—

211

(3009466) Valproate [Moles/volume] in Serum or Plasma

116

248

4.81

50.80

6.4

5.1

umol/l

384.1

363.6

0.79

107

210

(3000850) Epithelial cells [#/volume] in Urine

756

4431

1.92

48.90

3.2

2.3

e6/l

5.9

5.6

0.21

618

3839

(3002385) Erythrocyte distribution width [Ratio]

1697

21275

0.58

48.66

24.4

13.1

13.9

13.6

9.98

1671

20743

(3003458) Phosphate [Moles/volume] in Serum or Plasma

495

2499

2.15

48.53

8.1

5.2

mmol/l

1.0

0.34

484

2317

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

896

5581

1.83

47.68

2.6

2.0

mg/l

3.0

2.9

0.57

849

4721

(3012095) Magnesium [Moles/volume] in Serum or Plasma

576

3112

2.03

47.01

3.7

2.8

mmol/l

0.8

0.34

552

2904

(3045424) Erythrocytes [Presence] in Urine

146

395

3.82

47.00

2.0

1.5

—

(3006315) Basophils [#/volume] in Blood

1561

11442

1.69

46.28

8.5

5.1

e9/l

0.0

1.28

1484

9802

(3019060) Gas panel - Arterial blood

298

1234

2.55

46.08

4.3

4.7

—

(3013115) Eosinophils [#/volume] in Blood

1603

11868

1.68

45.47

8.7

5.3

e9/l

0.2

0.38

1523

10355

(3037522) Nuclear Ab [Titer] in Serum

540

2893

2.04

44.96

1.5

1.3

titre

578.8

526.4

0.22

136

577

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1275

8984

1.68

42.93

4.8

3.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

16.53

42.70

1.7

1.8

ng/l

115.4

128.1

0.15

(3042936) Bacteria identified in Isolate by Culture

541

2954

1.99

42.51

2.5

1.8

—

(3011288) Drugs identified in Urine by Screen method

190

648

3.05

42.45

5.9

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

297

1283

2.44

41.86

2.0

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

345

1596

2.30

41.62

4.8

7.1

mmol/l

1.4

1.3

1.03

297

1548

(3007164) IgA [Mass/volume] in Serum or Plasma

724

4381

1.84

41.52

1.7

1.4

g/l

2.2

2.4

2.93

610

2637

(3018095) Leukocytes [#/volume] in Urine

1142

7887

1.68

41.03

5.8

3.1

e6/l

52.9

90.1

2.77

1008

5296

(3028026) IgM [Mass/volume] in Serum or Plasma

267

1109

2.53

40.92

2.2

1.8

g/l

1.2

1.4

1.57

254

992

(3019977) pH of Arterial blood

7.26

40.69

1.3

3.0

7.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

222

844

2.75

40.65

4.4

2.1

0.7

0.6

2.02

206

804

(3000991) Gas panel - Venous blood

334

1540

2.30

40.57

6.0

8.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

113

284

4.08

40.29

1.9

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

421

2147

2.10

39.74

4.9

3.6

u/l

241.8

238.5

0.24

407

2027

(3001604) Monocytes [#/volume] in Blood

1523

11393

1.62

39.49

8.3

5.1

e9/l

0.6

1.85

1453

9766

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

124

342

3.73

38.82

1.3

1.5

e6/l

23.7

12.1

0.46

106

260

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

124

342

3.73

38.82

1.4

1.5

e6/l

5846.3

1801.3

0.41

111

278

(3019198) Lymphocytes [#/volume] in Blood

1564

11819

1.61

38.58

8.5

5.1

e9/l

1.9

2.08

1482

10348

(40758558) Short blood count panel - Blood

872

5680

1.73

38.44

7.3

5.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

344

1643

2.22

38.32

3.3

2.7

ng/l

212.5

192.9

0.39

309

1482

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

122

337

3.72

38.11

1.3

u/l

26.5

25.2

0.16

117

276

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

740

4614

1.78

37.98

1.7

1.5

mg/l

0.9

1.2

2.43

550

3471

(3020779) Urea [Moles/volume] in Serum or Plasma

354

1725

2.18

37.48

10.7

6.0

mmol/l

9.3

9.8

0.62

348

1629

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

126

5.65

37.21

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

126

5.65

37.21

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

126

5.65

37.21

1.4

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

650

3921

1.82

37.19

1.4

1.2

iu/ml

29.9

33.5

0.36

173

1233

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

624

3720

1.83

37.10

1.3

1.2

u/ml

19.3

12.6

0.65

369

1491

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

130

383

3.49

36.88

1.3

mg/l

888.6

528.1

0.92

120

363

(3011335) Digoxin [Mass/volume] in Serum or Plasma

16.46

36.66

2.1

2.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

199

761

2.72

35.98

5.6

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1416

10575

1.59

35.81

3.5

2.6

ug/l

116.5

112.8

0.31

1369

9795

(40768797) Stomach Pathology biopsy report

515

2926

1.90

35.50

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

134

418

3.30

34.75

1.3

1.2

—

(3022313) Gas panel - Capillary blood

220

900

2.55

34.72

3.9

3.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2021

16501

1.58

33.94

5.5

3.7

—

(4062490)

176

4.63

33.87

1.6

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1471

11217

1.56

33.14

5.5

3.7

—

(3000764) Benzodiazepines [Presence] in Urine

235

1027

2.39

32.12

5.2

2.0

—

(3016879) Cocaine [Presence] in Urine

222

946

2.44

32.09

5.4

2.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

258

1175

2.30

32.07

8.2

6.8

mmol/l

24.4

24.6

0.38

253

1089

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2825

25220

1.82

32.07

22.4

10.4

mg/l

22.2

23.6

1.62

2401

19162

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

134

440

3.13

31.93

1.6

—

(3027008) Opiates [Presence] in Urine

236

1037

2.37

31.86

4.3

2.0

—

(3026782) Osmolality of Urine

647

4061

1.74

31.78

4.6

2.4

mosm/kgh2o

509.7

560.2

7.56

607

3414

(3028300) Cannabinoids [Presence] in Urine

236

1040

2.37

31.65

5.2

2.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

8.96

31.58

1.5

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

199

4.25

31.54

1.7

1.4

—

(3027944) Amphetamines [Presence] in Urine

233

1023

2.37

31.51

5.3

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

319

1602

2.10

31.06

3.1

2.3

e9/l

75.9

68.5

2.45

284

1187

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

112

335

3.43

31.06

1.3

1.2

mmol/l

3.8

3.7

0.16

104

317

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

114

346

3.38

30.89

1.3

1.4

mmol/l

7.5

7.2

0.34

257

(3014576) Chloride [Moles/volume] in Serum or Plasma

432

2425

1.90

30.61

6.8

6.6

mmol/l

103.7

104.7

4.21

425

2373

(40761535) Cells panel - Urine sediment

343

1780

2.03

30.54

4.3

2.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

184

4.32

30.27

4.3

2.8

59.5

57.2

0.22

118

(3009508) Creatinine [Moles/volume] in Urine

1028

7348

1.58

30.01

4.2

3.1

mmol/l

7.3

7.7

2.65

962

6167

(3016502) Oxygen saturation in Arterial blood

360

1946

1.95

28.47

5.1

7.8

94.7

95.7

1.50

340

1877

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

135

476

2.91

28.42

1.5

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2618

23124

1.63

27.98

5.9

4.4

mu/l

1.8

2.1

2.02

2536

21137

(3028192) IgG subclass 2 [Mass/volume] in Serum

174

4.27

27.97

1.3

g/l

2.5

3.0

2.14

129

(3027135) IgG subclass 1 [Mass/volume] in Serum

174

4.27

27.97

1.3

g/l

5.9

6.8

1.46

129

(3024139) IgG subclass 3 [Mass/volume] in Serum

174

4.27

27.97

1.3

g/l

0.4

0.81

128

(3003181) Sodium [Moles/volume] in Urine

260

3.61

27.83

1.6

1.3

mmol/l

58.3

62.4

0.48

198

(3024354) Oxygen [Partial pressure] in Venous blood

276

1380

2.09

27.09

4.8

2.5

kpa

5.2

4.6

2.41

266

1336

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2666

23738

1.63

26.63

20.1

10.1

ml/min/173m2

82.0

82.7

0.78

2521

19119

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1987

16613

1.49

26.38

4.1

2.7

u/l

49.5

43.4

2.94

1905

15535

(3026493) Urate [Moles/volume] in Serum or Plasma

841

5901

1.57

25.91

3.3

2.3

umol/l

1602.0

5432.3

3.80

781

5150

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1030

7562

1.53

25.83

3.8

2.8

u/l

33.6

32.8

0.15

994

7175

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

108

357

3.09

25.48

2.0

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2231

19176

1.50

25.24

4.9

3.7

pmol/l

14.6

14.7

1.05

2148

17395

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1210

9222

1.49

25.20

2.0

1.8

pmol/l

93.8

96.1

1.04

705

4707

(3019550) Sodium [Moles/volume] in Serum or Plasma

2834

25758

1.70

24.65

22.7

12.2

mmol/l

139.4

139.8

12.02

2798

24966

(3004789) Transferrin [Mass/volume] in Serum or Plasma

477

2938

1.73

24.53

3.2

2.2

g/l

2.4

0.08

457

2718

(3023103) Potassium [Moles/volume] in Serum or Plasma

2841

25849

1.70

24.48

22.7

12.3

mmol/l

4.0

0.20

2805

25000

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

277

1444

2.00

24.21

2.4

2.3

au/ml

26.6

21.3

0.19

107

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.98

23.86

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.98

23.86

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.98

23.86

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.98

23.86

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

113

403

2.87

23.33

2.9

3.2

u/ml

282.7

217.7

0.20

106

370

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

6.06

22.47

3.8

1.5

umol/l

150.7

246.6

0.62

(3009261) Glucose [Presence] in Urine by Test strip

1461

11732

1.44

22.40

4.8

3.1

estimate

0.0

1.32

322

2022

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

373

2201

1.78

22.17

5.0

7.3

kpa

5.1

0.44

354

2097

(3027801) Oxygen [Partial pressure] in Arterial blood

373

2202

1.78

22.13

5.0

7.3

kpa

11.2

12.6

7.95

346

2100

(3048689) Calprotectin [Mass/mass] in Stool

447

2782

1.70

21.98

2.4

2.3

ug/g

107.6

123.4

0.83

374

2206

(3022948) Iron [Moles/volume] in Serum or Plasma

501

3225

1.65

21.65

3.2

2.2

umol/l

12.5

13.7

3.40

464

2979

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

136

558

2.50

21.32

4.8

3.0

mg/l

1.8

1.4

3.68

128

506

(3003396) Base excess in Arterial blood by calculation

367

2187

1.76

21.05

5.0

7.3

mmol/l

0.9

1.0

0.31

299

1714

(3025941) Bacteria identified in Stool by Culture

236

1228

1.99

20.69

1.4

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

142

4.07

20.67

1.8

1.2

promille

1.5

1.4

0.14

115

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

8.73

20.65

2.4

1.8

umol/l

13.6

17.3

0.74

(3023183) Ammonium ion [Moles/volume] in Plasma

330

2.93

20.60

2.8

2.4

umol/l

33.5

0.01

282

(3007853) Bacteria identified in Skin by Aerobe culture

408

2520

1.71

20.57

2.0

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

272

1491

1.90

20.45

2.5

2.4

g/l

66.6

66.9

0.23

259

1351

(3021960) Folate [Moles/volume] in Serum or Plasma

701

4950

1.53

20.28

1.5

nmol/l

19.3

20.7

1.89

643

4220

(3042517) Benzodiazepines panel - Urine

13.64

20.22

3.6

2.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

171

796

2.21

20.11

2.0

1.7

u/l

37.7

39.4

0.56

162

715

(3005322) IgE [Units/volume] in Serum or Plasma

254

1369

1.93

20.10

1.5

1.2

u/ml

163.4

219.5

0.82

235

1263

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

229

3.28

19.53

2.1

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

297

2.98

19.47

1.4

1.5

g/l

0.5

0.8

3.75

235

(3027945) Reticulocytes/100 erythrocytes in Blood

364

2234

1.71

18.71

2.9

2.3

2.0

1.7

3.20

340

1951

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

11.94

18.69

1.2

1.1

91.8

96.0

0.24

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

11.94

18.69

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

241

1309

1.91

18.62

1.3

au/ml

45.0

50.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

115

467

2.52

18.46

1.9

1.8

mg/l

7.4

11.0

5.30

108

434

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

721

5212

1.49

18.42

1.3

1.2

u/ml

1.0

1.8

2.99

350

1389

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

148

675

2.25

18.31

1.7

1.6

iu/ml

0.1

0.3

1.09

135

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

192

972

2.04

18.17

2.8

2.1

u/l

5785.9

5245.1

0.09

403

(3015171) Extractable nuclear Ab [Units/volume] in Serum

165

789

2.15

18.16

1.3

u/ml

1.3

1.7

0.18

(3001686) Cold agglutinin [Titer] in Serum or Plasma

8.05

17.89

1.1

1.5

—

37.3

—

(3022096) Basophils/100 leukocytes in Blood

1283

10349

1.39

17.86

8.3

5.3

0.6

0.7

2.38

1236

9579

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1206

9634

1.40

17.76

8.2

5.0

mmol/l

1.2

6.56

1138

8632

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.70

17.50

3.6

4.0

—

(3010421) pH of Blood

110

450

2.49

17.40

5.4

3.3

7.4

0.67

376

(40768804) Tissue Pathology biopsy report

1242

10002

1.39

17.31

2.3

2.0

—

(40767503) Oxygen content in Capillary blood by calculation

358

2.67

17.21

3.2

2.1

16.7

16.6

0.04

178

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

222

1209

1.90

17.01

6.3

9.2

2.0

1.3

10.94

222

1201

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

221

1206

1.89

16.83

6.3

9.4

0.8

0.7

4.49

221

1197

(3021601) Nitrite [Presence] in Urine by Test strip

1405

11598

1.37

16.58

5.7

4.2

estimate

0.0

0.50

339

2083

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

304

2.77

16.39

10.4

5.3

iu/ml

454.0

898.2

0.44

(1616796) Gas panel - Central venous blood

373

2.59

16.38

4.8

3.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

258

1490

1.79

16.38

4.5

3.7

ng/l

110.9

85.8

2.32

230

1283

(3000570) Elastase.pancreatic [Mass/mass] in Stool

119

519

2.34

16.37

1.5

1.4

ug/g

284.1

282.9

0.02

284

(3004588) Protein electrophoresis panel - Serum or Plasma

222

1224

1.87

16.37

2.3

—

(3006504) Eosinophils/100 leukocytes in Blood

1310

10717

1.37

16.27

8.4

5.2

2.8

2.9

0.72

1252

9912

(3009445) Proteinase 3 Ab [Units/volume] in Serum

154

749

2.11

16.24

1.3

1.5

u/ml

4.7

11.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

270

4392

0.58

16.22

3.3

3.0

ug/l

0.7

0.8

1.16

200

2844

(3019069) Monocytes/100 leukocytes in Blood

1316

10781

1.37

16.17

8.5

5.5

8.5

0.02

1260

10036

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

280

2.83

16.00

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

424

2812

1.58

15.93

2.1

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

350

2.62

15.83

1.7

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

410

2707

1.59

15.69

3.3

2.3

21.5

23.6

2.81

371

2291

(3002173) Hemoglobin [Mass/volume] in Arterial blood

298

1816

1.70

15.66

5.8

8.2

g/l

124.6

122.5

0.94

288

1745

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

103

4.12

15.61

2.2

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

130

3.73

15.57

1.2

2.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

356

2.57

15.31

2.4

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

233

2.96

15.19

1.2

1.3

nmol/l

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

649

2.14

15.08

2.4

2.3

g/l

2.4

3.1

12.20

510

(3048879) Bone marrow aspiration report

5.78

14.92

1.8

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2656

24463

1.43

14.76

5.0

4.2

mmol/l

6.0

5.9

2.29

2516

22308

(3020682) Albumin/Creatinine [Ratio] in Urine

914

7142

1.39

14.75

4.3

3.9

mg/mmol

11.1

7.8

0.88

659

4480

(3035350) Ketones [Presence] in Urine by Test strip

1382

11545

1.34

14.42

4.9

3.1

estimate

0.0

0.80

259

2054

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

187

3.14

14.40

2.2

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

433

2950

1.54

14.37

2.0

1.9

29.7

0.07

419

2857

(3000475) Leukocytes [#/volume] in Synovial fluid

110

492

2.28

14.31

1.9

1.7

e6/l

9639.7

12540.1

0.45

344

(3024263) Appearance of Synovial fluid

110

3.85

14.30

3.7

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2505

22879

1.39

14.26

6.5

5.3

mmol/mol

39.9

39.3

2.19

2411

21202

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

148

3.41

14.24

1.9

1.4

—

(3000494) Fungus identified in Specimen by Culture

393

2626

1.56

14.22

1.5

1.3

—

(3008295) Osmolality of Serum or Plasma

170

3.21

13.95

1.3

1.4

mosm/kgh2o

283.2

280.9

0.28

133

(3000330) Specific gravity of Urine by Test strip

1103

0.26

13.90

4.2

2.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

207

2.98

13.89

6.8

5.7

mg/l

12.3

11.6

0.48

193

(3041096) Erythrocytes [Presence] in Urine by Automated

823

6373

1.39

13.89

4.4

2.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

116

539

2.19

13.78

1.9

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

225

2.88

13.69

1.3

—

(4027681)

109

3.80

13.68

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

231

2.85

13.63

1.3

—

(3011985) Renin [Units/volume] in Plasma

249

2.77

13.50

1.4

mu/l

87.4

50.5

0.64

220

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

216

2.91

13.48

2.1

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

385

2.40

13.46

3.0

3.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

1335

11185

1.32

13.31

8.4

5.3

27.7

28.4

1.82

1282

10354

(4198724)

4.26

12.90

9.3

2.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

695

2.00

12.60

2.4

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

695

2.00

12.60

2.4

2.2

g/l

3.4

3.9

2.86

494

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

696

1.99

12.55

2.4

2.2

g/l

7.5

7.4

0.23

525

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

122

601

2.07

12.50

1.6

titre

513.3

360.8

—

(3018010) Neutrophils/100 leukocytes in Blood

1313

11043

1.31

12.50

7.9

5.1

57.7

57.0

1.40

1263

10274

(3011412) CD3 cells [#/volume] in Blood

142

3.27

12.30

2.6

2.3

e9/l

1.5

1.2

1.24

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

3.92

12.25

1.1

1.9

ug/l

18.4

384.8

0.69

(3024522) Salmonella sp identified in Specimen by Organism specific culture

228

2.75

12.24

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

247

2.66

12.05

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

424

2.25

12.04

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

447

3176

1.47

12.01

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

313

2.46

11.96

1.2

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

369

2.34

11.91

3.5

2.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

141

3.22

11.76

1.2

1.0

mg/l

235.5

278.8

0.95

128

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

173

2.98

11.67

1.5

33.5

32.0

0.08

111

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

5.71

11.47

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

242

2.63

11.45

1.3

1.4

pmol/l

499.9

282.2

1.24

187

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

284

2.50

11.39

2.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.56

11.16

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

122

629

1.98

11.06

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

229

2.65

11.06

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

229

2.65

11.06

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

230

2.64

10.97

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

3.42

10.96

2.8

2.5

e6/l

785.5

794.3

0.03

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

148

3.07

10.88

1.5

1.1

mg/l

30.3

43.3

2.10

126

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

110

550

2.03

10.87

2.3

2.4

ug/min

120.7

94.6

0.19

333

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

121

628

1.96

10.77

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

165

2.94

10.76

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

314

2.35

10.49

1.4

2.1

—

4.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

141

3.08

10.46

1.2

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

106

3.42

10.41

2.4

2.2

umol/l

20.0

32.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

5.43

10.39

1.5

2.7

mmol/l

7.2

8.1

0.30

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

455

3329

1.43

10.39

4.4

2.5

e6/l

4.7

2.5

4.24

379

1721

(3043238) Trisomy 21 risk [Likelihood] in Fetus

641

0.17

10.29

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

256

2.49

10.25

2.1

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

356

2.25

10.20

1.6

1.4

—

19.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

129

3.13

10.02

1.1

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

121

645

1.91

9.98

2.5

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

3.03

9.95

1.9

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

242

2.51

9.93

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

622

0.17

9.87

1.5

1.4

—

(3003694) ABO and Rh group [Type] in Blood

878

7167

1.31

9.87

1.4

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

221

1405

1.61

9.85

3.6

3.3

pmol/l

4.5

0.29

209

1260

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2873

27267

1.41

9.83

14.1

8.5

u/l

26.9

26.1

1.22

2834

26187

(3005033) Fetal Nuchal fold Thickness US

620

0.17

9.83

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

152

2.92

9.80

1.6

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.39

9.79

1.1

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

352

2.22

9.63

1.2

u/ml

251.8

267.1

0.18

219

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

757

0.26

9.59

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

756

0.26

9.57

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

755

0.26

9.55

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

753

0.26

9.51

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

128

3.07

9.50

1.1

1.2

—

(3008898) HLA-B27 [Presence]

140

796

1.79

9.44

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

600

4667

1.35

9.40

2.0

1.9

—

(40761511) CBC panel - Blood by Automated count

2535

26830

0.76

9.23

19.0

10.3

—

(3045414) Leukocytes [Presence] in Urine

170

1030

1.69

9.16

2.1

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

211

2.54

9.04

2.2

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

377

2.12

8.90

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

6.69

8.89

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

156

2.78

8.80

1.2

u/ml

6.0

54.7

—

(3012501) Base excess in Blood by calculation

382

2.09

8.61

5.7

3.4

mmol/l

2.5

0.04

248

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

215

1403

1.57

8.61

2.1

1.8

—

(3027315) Oxygen [Partial pressure] in Blood

383

2.09

8.56

5.7

3.4

kpa

8.8

8.7

0.42

376

(3013290) Carbon dioxide [Partial pressure] in Blood

383

2.09

8.56

5.7

3.4

kpa

5.0

0.09

377

(3002256) Pathology report gross observation

426

3185

1.39

8.52

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

159

2.73

8.50

1.2

u/ml

25.6

35.1

—

(3016038) Potassium [Moles/volume] in Urine

3.28

8.47

1.5

1.2

mmol/l

32.3

34.8

0.29

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.68

8.44

1.1

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2576

24185

1.29

8.44

4.5

3.7

mmol/l

1.4

1.3

6.71

2481

22221

(3010144) Erythrocytes [#/volume] in Synovial fluid

183

2.59

8.41

1.4

e6/l

12811.5

49033.2

0.53

126

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

103

553

1.89

8.37

1.6

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

106

3.13

8.37

1.2

1.0

u/l

1.0

1.1

0.42

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

106

575

1.87

8.35

2.8

2.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

6.11

8.18

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

22.07

8.01

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

224

2.39

8.00

3.1

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

106

587

1.83

7.85

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

165

2555

0.63

7.85

1.6

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.59

7.84

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

149

2.71

7.82

2.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

111

2.99

7.76

2.4

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

111

2.99

7.76

1.9

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

324

2.12

7.74

1.6

1.4

u/ml

97.7

108.3

0.55

(3008536) Aspergillus sp Ab [Presence] in Serum

6.21

7.71

1.7

2.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

244

1686

1.48

7.51

1.2

iu/ml

87.8

157.2

2.87

119

629

(3012516) Albumin [Mass/volume] in Urine

812

6763

1.27

7.47

3.6

3.2

mg/l

253.7

172.7

0.29

567

4218

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

142

2.70

7.40

2.0

1.5

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

+∞

7.29

1.4

0.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

6.34

7.24

1.5

4.7

umol/l

42.9

32.8

0.92

(3010375) cycloSPORINE [Mass/volume] in Blood

3.45

7.11

35.4

22.3

ug/l

111.2

111.3

0.00

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.06

7.07

1.1

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

310

2.09

7.02

1.1

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

100

564

1.80

7.01

1.8

2.2

ug/l

241.3

595.1

1.84

523

(3006653) Thiamine [Moles/volume] in Blood

3.16

6.98

1.1

1.2

nmol/l

134.9

133.4

0.06

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.20

6.96

26.9

10.4

mmol/l

5.4

6.1

0.35

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

515

1.83

6.93

2.9

3.3

ratio

2.4

3.0

0.13

(3034860) Kappa light chains.free [Mass/volume] in Serum

537

1.81

6.92

3.1

3.3

mg/l

39.1

69.9

1.45

449

(3035880) pH of Pleural fluid

108

2.89

6.89

1.1

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

480

1.86

6.88

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

229

2.25

6.76

1.5

1.6

62.4

60.0

0.14

145

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.27

6.74

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

536

1.80

6.67

3.1

3.3

mg/l

31.8

57.5

1.07

449

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

212

3013

0.68

6.65

3.9

4.3

31.6

32.4

0.50

168

2004

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

111

2.81

6.57

1.7

2.0

10.7

14.2

1.31

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.18

6.56

1.2

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.52

6.43

1.6

2.7

u/ml

731.6

1153.2

0.44

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.74

6.36

3.8

2.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.06

6.35

1.0

1.1

umol/24h

1.9

0.8

—

(3030313) Adrenal Ab [Titer] in Serum

6.68

6.31

1.2

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.90

6.31

1.1

miu/ml

1641.6

1454.5

0.28

(3007566) Smooth muscle Ab [Titer] in Serum

568

1.75

6.30

1.1

1.2

titre

77.3

88.3

0.26

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.23

6.28

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

550

0.31

6.27

3.5

3.0

mg/l

18.8

28.3

—

346

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

811

0.43

6.27

1.3

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

186

1268

1.49

6.16

1.1

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

115

702

1.66

6.13

1.7

—

(3044927) Protein electrophoresis panel - Urine

169

2.38

6.12

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.77

6.08

1.7

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.77

6.08

1.7

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.77

6.08

1.7

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

12.53

6.08

1.2

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.17

6.01

2.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.17

6.01

2.6

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

246

1781

1.41

5.95

2.3

1.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

394

1.87

5.95

3.5

3.6

57.1

0.01

394

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.69

5.91

1.5

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

15.03

5.90

1.3

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

5.89

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.61

5.75

1.6

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

107

654

1.66

5.70

1.5

1.3

u/l

9.8

9.7

0.02

100

538

(40768443) Skin Pathology biopsy report

146

963

1.54

5.67

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

129

1959

0.64

5.65

3.2

2.1

u/l

33.4

67.4

0.77

118

1663

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

275

2.02

5.61

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.82

5.53

1.3

1.1

—

(36660697) Celiac disease serology panel - Serum

121

1853

0.64

5.51

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.15

5.46

1.1

2.1

mg/l

7937.0

62.6

0.48

(3022621) pH of Urine by Test strip

212

1522

1.42

5.40

2.8

2.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

268

2008

1.36

5.30

2.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

360

1.85

5.25

1.4

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

511

0.35

5.18

2.4

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

348

2720

1.31

5.17

1.9

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

290

2212

1.34

5.11

5.0

2.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

267

2017

1.35

5.02

2.1

1.5

—

(40768446) Kidney Pathology biopsy report

2.97

4.98

2.1

1.5

—

(42870588) Differential panel, method unspecified - Blood

861

7488

1.20

4.97

8.4

5.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1431

0.62

4.87

1.4

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

631

5334

1.23

4.86

4.6

3.1

—

(3047181) Lactate [Moles/volume] in Blood

605

1.62

4.83

3.3

5.8

mmol/l

1.5

1.2

2.06

532

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

113

2.49

4.79

10.4

2.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2639

25291

1.21

4.75

5.0

4.1

mmol/l

4.6

4.7

4.66

2534

23532

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2623

25127

1.21

4.72

4.8

4.0

mmol/l

1.4

1.5

5.56

2525

23228

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

351

1.81

4.72

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

287

1.90

4.69

1.2

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

191

2.11

4.67

4.1

3.1

u/ml

29.4

45.8

0.72

191

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

260

1.94

4.63

1.3

1.8

—

2160.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1794

16659

1.17

4.63

3.3

3.0

—

(3021788) Differential panel - Synovial fluid

355

1.79

4.56

1.5

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

167

2.17

4.52

3.4

2.6

—

(3035285) Chloride [Moles/volume] in Venous blood

242

0.25

4.47

6.0

2.0

mmol/l

104.8

105.8

—

237

(3041354) Potassium [Moles/volume] in Venous blood

242

0.25

4.47

6.0

2.0

mmol/l

4.0

4.1

—

237

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

380

1.75

4.45

3.0

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

443

0.36

4.43

1.2

1.7

—

(44790047)

182

2.10

4.42

2.3

1.4

—

(44790048)

182

2.10

4.42

2.3

1.4

—

(44790049)

182

2.10

4.42

2.3

1.4

—

(44806118)

182

2.10

4.42

2.3

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

500

0.40

4.41

1.1

2.3

g/l

0.0

0.00

452

(3000012) Reticulocyte production index

2.56

4.38

1.6

1.3

—

(3044889) 12 lead EKG panel

1569

16927

0.86

4.35

4.2

3.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.66

4.32

1.3

1.4

55.0

65.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

495

0.40

4.31

1.1

2.3

g/l

0.0

0.00

452

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.60

4.30

2.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.56

4.30

1.5

1.3

—

(1002224) Polysomnography panel

1045

0.59

4.29

1.1

—

(21494755) Public health laboratory ask at order entry panel

214

2820

0.74

4.28

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

415

1.70

4.27

3.0

2.1

g/l

132.7

130.9

0.25

283

(3033705) Calcium.ionized [Moles/volume] in Venous blood

235

0.25

4.18

6.0

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.75

4.18

1.1

2.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

456

1.66

4.18

2.4

1.8

pmol/l

178.1

204.9

1.63

429

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

109

2.40

4.14

1.0

1.1

nmol/l

9.4

12.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

272

1.85

4.09

1.5

g/l

32.6

0.01

252

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

284

3576

0.77

4.08

2.7

2.4

e6/l

1.9

1.2

0.80

206

1957

(3038515) Glucose [Moles/volume] in Venous blood

407

0.37

4.01

4.7

2.5

mmol/l

7.5

0.00

397

(3049717) Cytology report of Urine Cyto stain

117

797

1.49

4.00

2.8

2.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

143

2.18

3.98

1.4

1.2

u/ml

0.3

1.3

0.64

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2670

25726

1.20

3.98

5.2

4.5

mmol/l

2.7

2.8

2.61

2563

23765

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

131

2.22

3.92

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

599

1.55

3.90

3.3

2.6

u/ml

0.4

0.3

0.34

312

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

4.18

3.88

1.0

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

471

5572

0.82

3.87

4.4

3.2

91.9

91.4

0.15

459

5446

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1064

0.61

3.85

8.1

10.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

121

837

1.46

3.85

1.4

1.3

miu/ml

268.9

219.2

0.62

414

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

121

1717

0.69

3.83

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.61

3.80

2.6

1.6

umol/l

1.8

2.1

0.64

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

122

848

1.46

3.79

1.6

g/l

1.5

0.09

110

726

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

560

0.48

3.74

1.1

2.2

g/l

39.4

38.2

0.34

472

(3019420) Tryptase [Mass/volume] in Serum or Plasma

109

2.30

3.68

1.4

1.6

ug/l

6.1

8.6

0.75

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

512

1.58

3.67

1.4

1.2

—

(3000492) Spirometry study

177

2339

0.74

3.64

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

131

934

1.42

3.57

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

920

0.60

3.56

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.85

3.52

1.1

—

(3003338) MCHC [Mass/volume]

2317

22152

1.15

3.46

23.8

13.9

g/l

331.5

332.6

7.01

2307

21972

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.54

3.46

1.4

1.6

59.5

69.2

0.36

(3016018) Differential panel - Cerebral spinal fluid

159

2.02

3.44

1.2

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.77

3.42

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

848

0.60

3.42

1.3

1.5

—

(3017569) Oxygen content in Arterial blood

2.35

3.40

1.5

2.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

219

1709

1.30

3.36

2.8

2.1

nmol/l

11.8

12.7

1.01

204

1525

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.25

3.34

1.3

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

5.73

3.34

1.1

mmol/l

7.8

8.0

—

(3030467) Casts [#/volume] in Urine by Automated count

673

5914

1.17

3.32

3.3

2.7

e6/l

0.5

0.4

0.24

509

4315

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.58

3.26

4.2

4.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.79

3.25

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.67

3.22

1.1

1.0

89.6

95.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

270

2178

1.26

3.20

3.6

3.9

ug/l

9.1

18.8

0.93

217

1722

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.74

3.15

1.1

1.0

85.9

97.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.41

3.13

2.0

3.1

au/ml

335.0

44.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

574

1.49

3.11

1.3

1.2

u/ml

14.0

40.2

0.97

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

313

1.67

3.10

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

202

1.84

3.07

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

232

2887

0.79

3.05

7.0

5.7

—

(3021589) Normoblasts [#/volume] in Blood

1153

10588

1.14

3.05

14.5

7.6

e9/l

0.0

0.46

1034

8613

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

5.84

3.02

1.4

nmol/l

26.4

9.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

418

1.57

2.99

1.3

u/ml

23.4

2.0

0.72

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

127

2.06

2.96

1.7

1.4

u/ml

23.4

18.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.64

2.96

1.4

1.3

—

(44806420)

0.00

2.96

0.0

2.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

716

0.60

2.94

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

236

2915

0.79

2.92

1.6

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.71

2.92

1.0

1.1

—

(36304419) Bacteria [Presence] in Urine

509

5832

0.85

2.89

3.2

2.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

527

1.49

2.88

1.3

1.2

u/ml

12.9

2.8

0.42

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.59

2.87

1.6

2.0

e6/l

394.8

987.3

1.39

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

297

1.66

2.87

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

178

1.86

2.86

1.2

2.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.30

2.84

2.3

3.8

mg/l

8.5

8.1

0.05

(3023199) Leukocytes [#/volume] in Pleural fluid

245

1.72

2.83

1.4

e6/l

1753.6

2193.5

0.43

176

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

165

1.89

2.80

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

532

1.48

2.76

1.3

u/ml

8.9

6.7

0.19

(3037121) Protein [Mass/volume] in Urine

100

716

1.41

2.74

3.5

3.0

g/l

0.2

0.3

0.18

281

(3007461) Platelets [#/volume] in Blood

2951

28886

1.20

2.71

31.6

16.0

e9/l

253.8

252.6

0.47

2933

28052

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

6.01

2.70

1.2

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

212

1.75

2.66

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

343

1.58

2.65

1.1

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

571

0.57

2.65

3.5

2.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

415

1.53

2.64

1.7

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

427

0.51

2.61

3.6

2.5

mmol/l

1.4

1.7

1.24

415

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.67

2.59

1.0

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.67

2.59

1.0

—

(3024731) MCV [Entitic volume]

2951

28906

1.19

2.58

31.4

15.9

90.8

0.05

2933

28426

(3035941) MCH [Entitic mass]

2951

28906

1.19

2.58

31.4

15.9

30.2

30.3

1.01

2931

28425

(3010813) Leukocytes [#/volume] in Blood

2952

28918

1.19

2.57

31.6

16.0

e9/l

6.8

6.7

1.98

2921

27992

(3026361) Erythrocytes [#/volume] in Blood

2951

28911

1.19

2.54

31.5

16.0

e12/l

4.5

5.98

2928

27990

(3050794) Legionella sp Ab [Presence] in Serum

5.46

2.54

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

5.46

2.54

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.27

2.50

1.0

1.1

—

4.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

2951

28920

1.19

2.48

31.7

16.1

g/l

134.6

136.2

7.57

2933

28435

(3014891) Appearance of Pleural fluid

3.47

2.48

2.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

911

0.67

2.48

1.8

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

193

1547

1.26

2.47

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.82

2.46

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

144

1113

1.31

2.45

2.2

2.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

175

0.34

2.40

5.7

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

105

1400

0.74

2.38

1.5

—

(3007463) Buprenorphine [Presence] in Urine

6.26

2.37

4.2

2.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

132

1.90

2.35

1.5

2.3

40.2

50.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.26

2.34

4.0

2.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

648

0.63

2.33

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

594

1.41

2.33

1.9

iu/l

3.7

4.1

0.31

215

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

299

1.58

2.33

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

112

1.97

2.30

2.1

1.4

umol/l

56.5

27.8

2.24

107

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

364

1.52

2.30

1.1

iu/ml

13.4

1430.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

192

1.73

2.29

1.5

1.6

mmol/l

8.0

7.6

0.44

119

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

580

6473

0.87

2.29

1.6

mmol/l

1.4

1.3

1.81

497

5465

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

200

1.71

2.28

1.2

—

(40761536) Microorganisms panel - Urine sediment

238

1973

1.22

2.27

5.0

3.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.62

2.27

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.48

2.27

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

221

2667

0.82

2.25

1.4

—

(4035726)

232

1923

1.22

2.22

1.5

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.56

2.21

1.4

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

360

1.51

2.20

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.51

2.18

1.8

2.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

227

1887

1.22

2.13

2.4

2.1

g/l

0.2

1.24

213

1780

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

306

0.49

2.12

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

190

1.69

2.09

1.3

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.08

2.06

3.1

1.5

umol/l

25.6

29.4

0.60

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

139

1099

1.28

2.04

6.9

7.2

mmol/l

24.6

24.8

0.32

139

1092

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.08

2.01

1.0

1.2

umol/24h

1.6

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.01

2.00

1.1

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.82

2.00

1.7

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

1.96

1.7

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.34

1.96

2.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.08

1.96

1.4

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.36

1.95

1.3

1.1

34.4

14.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.97

1.93

1.1

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.75

1.93

1.0

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

282

1.53

1.92

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

396

0.58

1.90

1.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.96

1.90

1.1

iu/ml

166.0

211.5

0.43

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

174

0.40

1.89

1.7

1.3

—

1.5

—

(3017509) Phencyclidine [Presence] in Urine

3.19

1.88

4.0

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.86

1.86

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

159

1.70

1.85

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

663

6051

1.12

1.85

4.5

4.3

22.2

21.9

0.20

299

2942

(4094501)

611

0.67

1.84

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.53

1.83

1.8

2.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

1.1

—

0.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

444

1.40

1.80

4.5

1.9

nmol/l

0.8

0.04

369

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

127

1012

1.27

1.79

4.6

9.7

mmol/l

24.5

24.3

0.19

950

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.76

1.79

1.5

2.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

811

7506

1.11

1.74

4.9

ug/l

3.0

2.9

0.01

764

6673

(3042733) HLA Ab [Presence] in Serum

2.23

1.73

3.9

4.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.06

1.70

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.06

1.70

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

433

3872

1.14

1.69

1.8

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

357

0.59

1.68

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

357

0.59

1.68

1.2

1.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.58

1.66

1.1

1.4

nmol/l

6.2

4.8

—

(3036489) Thrombin time

739

1.29

1.64

1.9

1.7

19.9

21.4

1.25

644

(3027456) Digoxin [Moles/volume] in Serum or Plasma

368

1.42

1.64

2.3

3.0

nmol/l

0.8

0.22

279

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.98

1.64

1.9

3.2

—

(3045142) Bone marrow Pathology biopsy report

181

1.61

1.63

1.2

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.58

1.61

1.0

1.1

—

0.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.50

1.59

4.4

4.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.07

1.59

1.5

1.6

ug/l

8.3

0.00

(3003888) Timothy IgE Ab [Units/volume] in Serum

438

1.38

1.59

1.2

1.1

u/ml

5.9

6.8

0.14

231

(3020393) Adenovirus Ag [Presence] in Stool

3.00

1.58

1.3

1.0

—

(4146454)

248

0.52

1.57

3.0

2.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

223

1.53

1.56

1.4

e6/l

82762.7

78071.9

0.02

136

(40768441) Liver Pathology biopsy report

160

1.63

1.55

1.7

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.11

1.55

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

282

1.46

1.52

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

185

1.57

1.51

1.1

1.3

titre

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.86

1.50

1.8

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

300

1.44

1.49

1.3

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

729

0.74

1.44

2.5

3.3

u/ml

49.4

2337.4

0.97

612

(3045462) Protein/Creatinine [Ratio] in Urine

3.13

1.44

4.0

5.2

g/mol

25.9

31.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.73

1.43

1.3

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.73

1.43

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

125

1.68

1.43

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

208

2406

0.86

1.40

4.2

2.3

umol/l

8.4

8.2

0.03

182

2088

(3034274) Bile acid [Moles/volume] in Serum --fasting

304

1.42

1.40

2.7

2.2

umol/l

5.3

5.6

0.13

223

(3010726) Horse dander IgE Ab [Units/volume] in Serum

406

1.36

1.40

1.1

u/ml

2.6

2.0

—

104

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.42

1.39

2.9

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.42

1.39

2.9

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.42

1.39

2.9

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.42

1.39

1.6

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

347

1.39

1.38

1.1

1.2

u/l

37.4

34.5

0.08

293

(4211845)

120

0.42

1.37

4.4

3.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.94

1.36

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

506

4635

1.11

1.34

1.7

1.5

—

(3025130) Human papilloma virus identified in Specimen

358

0.64

1.34

2.0

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

106

861

1.24

1.34

1.4

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

104

844

1.24

1.32

5.3

3.4

mmol/l

24.5

24.0

0.80

761

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

2.04

1.32

1.7

1.6

—

147.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

146

0.48

1.31

1.6

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

292

1.41

1.30

1.0

u/ml

0.1

0.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

204

1768

1.16

1.29

1.7

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.78

1.28

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.29

1.26

1.6

1.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

108

886

1.23

1.26

1.6

1.7

mu/l

388.7

304.1

0.97

100

806

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

211

1.47

1.25

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

778

0.77

1.25

4.4

4.8

1.6

1.7

0.28

726

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

363

1.36

1.24

1.7

1.4

nmol/l

0.2

0.5

3.36

300

(3019832) Treponema pallidum Ab [Presence] in Serum

296

2642

1.13

1.24

1.6

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.86

1.23

1.4

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

356

1.35

1.22

1.0

u/ml

11.2

2.9

0.53

134

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

124

1.62

1.20

2.1

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

648

1.26

1.19

2.2

2.3

g/l

9.9

10.3

0.27

550

(3047189) Immunofixation for 24 hour Urine

1.75

1.19

1.1

1.6

—

(3044941) Cell count panel - Synovial fluid

335

0.65

1.18

1.8

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

480

1.30

1.18

1.1

u/ml

1.4

1.2

0.08

187

(3008401) Mugwort IgE Ab [Units/volume] in Serum

419

1.32

1.18

1.1

u/ml

0.6

1.2

0.77

180

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.71

1.17

1.5

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1013

0.80

1.16

1.6

mg/l

4.9

4.0

0.18

676

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1108

0.82

1.13

1.8

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

572

0.75

1.10

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.67

1.10

1.5

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.76

1.06

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.12

1.05

1.6

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

122

1.56

1.02

1.8

1.6

u/l

3.5

4.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.18

0.98

1.4

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

199

0.60

0.96

1.0

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

0.00

0.96

0.0

1.0

—

41.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

149

1.48

0.95

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

198

0.60

0.95

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

605

1.23

0.95

2.2

2.3

g/l

0.4

0.9

1.77

513

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.95

0.0

7.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.77

0.94

1.3

1.4

nmol/l

147.0

143.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

118

0.51

0.94

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.22

0.93

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.72

0.92

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

279

1.33

0.90

4.1

2.4

u/ml

64.4

1036.4

0.49

255

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.07

0.89

1.3

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

206

0.63

0.88

4.5

2.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.65

0.88

1.2

1.1

—

(3017704) Immunofixation for Urine

1.61

0.87

1.1

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

220

1.37

0.87

3.7

4.7

u/ml

25.3

90.8

1.31

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

169

1.42

0.87

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.00

0.87

2.0

pmol/l

43.2

41.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.00

0.87

1.2

—

(40768795) Lymph node Pathology biopsy report

161

1.43

0.86

1.1

—

(3032080) INR in Blood by Coagulation assay

901

8613

1.06

0.85

10.3

7.8

inr

1.2

0.43

435

2467

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.94

0.84

1.8

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.74

0.82

2.6

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.69

0.82

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

113

1.51

0.82

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

180

1.39

0.81

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

364

0.74

0.81

3.7

3.1

u/ml

37.3

28.7

0.25

356

(3044242) Glucose [Moles/volume] in Arterial blood

1.55

0.81

1.5

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

122

1.48

0.80

1.4

1.1

—

(3042631) Mycobacterium sp identified in Specimen

224

1.34

0.79

2.5

3.0

—

(3028433) Virus identified in Specimen by Culture

1.73

0.79

1.7

1.1

—

(4306422)

312

1.29

0.79

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

1.82

0.79

1.2

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.78

0.0

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

131

1.45

0.78

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

331

1.27

0.77

1.0

1.1

u/ml

2.1

2.6

0.26

169

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.70

0.75

1.6

1.9

—

(4010399)

141

1588

0.88

0.75

1.6

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

133

1.43

0.73

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.64

0.73

1.4

2.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.62

0.71

1.6

1.4

46.3

53.4

0.24

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

638

1.18

0.69

1.3

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

228

0.70

0.69

1.4

1.1

91.5

97.2

0.51

216

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.85

0.68

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.85

0.68

5.2

2.1

mmol/l

0.7

1.8

—

(3012441) Differential panel - Pleural fluid

214

1.31

0.66

1.5

—

(3020491) Glucose [Moles/volume] in Blood

179

0.67

0.66

2.0

1.6

mmol/l

8.4

6.7

—

121

(4024509)

211

0.71

0.62

1.3

1.6

—

(44806071)

1.67

0.61

1.6

1.0

—

(40768793) Breast Pathology biopsy report

544

0.82

0.61

1.3

—

(3024471) HLA-A [Type]

1.60

0.61

1.0

—

(3024932) HLA-DR beta [Type]

1.54

0.59

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

1.54

0.59

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

140

1.36

0.58

1.6

2.1

ug/l

2.1

3.6

—

129

(3014765) Yersinia sp identified in Stool by Organism specific culture

643

1.15

0.56

1.3

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

203

1.28

0.55

7.2

3.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

649

1.14

0.51

1.3

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

179

1.29

0.51

1.0

mg/l

298.9

287.2

0.31

157

(3013637) Mi-2 Ab [Presence] in Serum

1.56

0.49

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.56

0.49

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.56

0.49

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.56

0.49

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

119

0.67

0.45

1.3

1.7

—

(3015183) Erythrocyte sedimentation rate

140

0.71

0.43

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

104

1.35

0.43

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

424

1.16

0.42

1.3

1.2

u/ml

45.1

39.2

—

(3004451) EKG impression Narrative

0.64

0.42

1.3

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.52

0.41

1.2

1.1

—

8.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.41

0.0

2.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.41

0.0

2.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

250

1.20

0.40

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(4212803)

0.00

0.40

0.0

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

560

0.87

0.39

1.4

pmol/l

107.0

181.3

1.02

550

(3006922) Hepatitis E virus Ab [Presence] in Serum

142

1.27

0.38

1.0

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

184

1725

1.07

0.38

4.5

2.9

mmol/l

1.2

2.60

163

1473

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

345

0.84

0.38

1.4

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.31

0.37

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

143

1.26

0.37

1.1

1.0

u/ml

0.2

4.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.29

0.36

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

481

0.87

0.36

1.4

1.2

—

(40768806) Pleura Pathology biopsy report

212

0.80

0.35

1.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

154

1.24

0.34

1.1

1.5

umol/l

13.9

12.0

0.32

146

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

321

1.15

0.33

1.2

u/ml

1.8

3.7

—

106

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

410

4249

0.96

0.32

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

111

0.72

0.28

1.5

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

0.76

0.27

1.3

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

187

1.18

0.26

1.1

1.3

pmol/l

98.8

75.2

—

(3034426) Prothrombin time (PT)

1.19

0.26

1.4

1.2

—

(4133840)

0.68

0.26

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.25

0.25

1.3

1.1

—

(3018418) pH of Serum or Plasma

609

6232

0.97

0.25

4.9

3.4

7.4

0.28

155

1136

(3009871) Measles virus Ab [Titer] in Serum

1.22

0.25

1.6

1.7

—

(3045788) Cell count panel - Pleural fluid

191

0.84

0.24

1.1

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.22

0.22

1.6

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.22

0.22

1.6

2.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

286

1.12

0.21

1.1

g/l

1.6

1.5

1.57

252

(21494434) Karyotype in Bone marrow

163

1.17

0.21

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

163

1.17

0.21

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

26.8

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

8.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

102

0.78

0.21

1.3

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

103

0.78

0.21

1.8

1.1

u/l

28.5

14.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.24

0.21

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

136

1.18

0.20

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.18

0.19

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

118

1.19

0.19

1.4

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

328

1.10

0.18

1.0

1.1

u/ml

1.5

3.2

—

129

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

164

0.85

0.18

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

100

1.20

0.18

3.9

2.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

319

1.10

0.18

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

651

0.94

0.17

2.1

1.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.15

0.17

3.6

5.1

mmol/l

26.7

25.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

466

1.07

0.16

1.2

—

(3022145) Colonoscopy Study observation

261

2542

1.03

0.16

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

141

1.14

0.14

5.6

6.5

—

(44813793)

170

1.12

0.13

1.2

1.0

—

(1761868) Lipid panel - Serum or Plasma

943

9523

0.99

0.13

2.5

2.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

326

1.07

0.12

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

393

0.94

0.10

3.6

2.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

144

1.11

0.10

3.3

1.6

—

(4281824)

241

1.08

0.10

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.15

0.10

1.5

1.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

145

0.90

0.09

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

145

0.90

0.09

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

145

0.90

0.09

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.03

0.08

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.08

0.08

2.9

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.08

0.07

2.1

2.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

398

0.95

0.07

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

143

0.91

0.07

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

143

0.91

0.07

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

143

0.91

0.07

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

108

1.11

0.07

1.5

1.1

u/l

118.4

74.2

0.55

(3023323) Follitropin [Units/volume] in Serum or Plasma

119

1164

1.02

0.07

1.4

1.3

iu/l

29.2

27.2

0.27

104

1001

(3003740) Influenza virus B Ag [Presence] in Specimen

397

0.96

0.07

1.4

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

538

0.97

0.06

3.1

3.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

588

0.97

0.06

2.2

1.7

—

(3004775) Volume in Urine collected for unspecified duration

182

0.93

0.05

2.7

2.2

723.2

583.7

0.80

126

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

110

0.91

0.05

1.2

1.7

u/field

4.3

4.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

313

0.96

0.05

1.3

1.2

u/ml

2.3

5.7

1.82

127

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

118

0.93

0.02

1.1

—

(3016750) Collection duration of Urine

142

1.06

0.02

2.9

2.0

min

521.2

487.1

—

108

(4268621)

218

0.96

0.02

2.0

2.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

647

0.99

0.01

1.0

1.1

u/ml

3.7

4.1

—

(3017732) Neutrophils [#/volume] in Blood

165

1657

1.00

0.00

4.1

2.8

e9/l

3.9

4.1

0.74

136

1321

(3011648) Oxygen content in Venous blood

172

0.99

0.00

3.5

1.9

11.5

11.2

0.10

172

(3032773) Endomysium IgG Ab [Titer] in Serum

198

1.01

0.00

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

514

0.99

0.00

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

196

1.02

0.00

3.6

3.7

—

(3051651) Icteric interference index of Serum or Plasma

114

0.96

0.00

4.6

2.7

—

(3051593) INR in Capillary blood by Coagulation assay

0.99

0.00

3.6

11.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

129

1290

1.00

0.00

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.92

0.00

2.5

1.4

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.00

0.00

1.2

1.1

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.02

0.00

5.0

6.0

69.6

74.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.90

0.00

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

130

1.00

0.00

1.0

—

0.3

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

190

1.00

0.00

1.5

1.2

u/l

82.6

58.1

0.59

125

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

218.5

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.92

0.00

2.5

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_UNKNO_UNSPE_CAUSES_MORBIDI – Unknown and unspecified causes of morbidity

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Unknown and unspecified causes of morbidity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Unknown and unspecified causes of morbidity (R18_UNKNO_UNSPE_CAUSES_MORBIDI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints